-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Ambrx Biopharma, Inc. quarterly Nonoperating Income (Expense) history and growth rate from Q3 2022 to Q3 2023.
- Ambrx Biopharma, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2023 was $2.79M, a 647% increase year-over-year.
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)